基质衍生序列在蛋白酶抑制抗体中起到作为基位阻断基因的作用
Hyunjun Choe1,2, Tara Antee2, Xin Ge1,2
1Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, Texas, USA.
概括
研究人员开发了一种新的方法,通过使用基质类序列来创建向蛋白酶的抗体抑制剂. 这种方法增强了针对蛋白酶相关疾病的向治疗方法的开发.
科学领域:
- 生物化学 生物化学
- 免疫学 免疫学 免疫学
- 药物发现 药物发现 药物发现
背景情况:
- 蛋白酶在生理过程中起着至关重要的作用.
- 不调节的蛋白质分解有助于各种疾病,突出显示了对向抑制剂的需求.
- 单克隆抗体为特定蛋白酶抑制提供了一个有前途的治疗策略.
研究的目的:
- 测试假设基质类序列可以在抗体内作为蛋白酶基位阻断基因的功能.
- 设计一种抗MMP-14的Fab抗体,以结合MMP-14基质库.
- 为了证明基质衍生序列在蛋白酶特异性抗体中作为抑制动机的潜力.
主要方法:
- 在抗MMP-14 Fab的CDR-H3.3中构建一个代表MMP-14基质配置文件 (P1-P5') 的退化编码子库.
- 通过菌体选选择MMP-14活性位点结合剂.
- 确定最佳的残留物和突变组合,以增强抑制活性.
主要成果:
- 丰富了各种类似基质的序列,使其具有对MMP-14的抑制功效.
- 在P1-P5'位置确定最佳残留物.
- 工程抗体变体显示出作为有效的MMP-14抑制剂的改进特征.
结论:
- 基质衍生的序列可以有效地作为蛋白酶特异性抗体中的抑制动机.
- 这种方法提供了一种多功能策略,用于产生针对各种蛋白酶的抗体抑制剂.
- 该研究验证了一种基于抗体的蛋白酶抑制的新方法,具有广泛的治疗意义.
更多相关视频
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
11.4K
06:50Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions
Published on: January 26, 2024
1.9K
相关概念视频
Enzyme Inhibition
78.8K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
78.8K
Enzymes
82.0K
Inside living organisms, enzymes act as catalysts for many biochemical reactions involved in cellular metabolism. The role of enzymes is to reduce the activation energies of biochemical reactions by forming complexes with its substrates. The lowering of activation energies favor an increase in the rates of biochemical reactions.
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
82.0K
Allosteric Proteins-ATCase
5.8K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.8K
Ligand Binding and Linkage
4.8K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.8K
Conserved Binding Sites
4.2K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
4.2K
Protein-protein Interfaces
12.6K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.6K
